Table of Contents
2019-2024 Global Personalized Medicine and Epigenomics Market Report (Status and Outlook)
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Personalized Medicine and Epigenomics Market Size 2014-2024
2.1.2 Personalized Medicine and Epigenomics Market Size CAGR by Region
2.2 Personalized Medicine and Epigenomics Segment by Type
2.2.1 Reagents
2.2.2 Kits
2.2.3 Instruments
2.2.4 Enzymes
2.2.5 Services
2.3 Personalized Medicine and Epigenomics Market Size by Type
2.3.1 Global Personalized Medicine and Epigenomics Market Size Market Share by Type (2014-2019)
2.3.2 Global Personalized Medicine and Epigenomics Market Size Growth Rate by Type (2014-2019)
2.4 Personalized Medicine and Epigenomics Segment by Application
2.4.1 Oncology
2.4.2 Non-Oncology
2.4.3 Cancer Drug Technology
2.5 Personalized Medicine and Epigenomics Market Size by Application
2.5.1 Global Personalized Medicine and Epigenomics Market Size Market Share by Application (2014-2019)
2.5.2 Global Personalized Medicine and Epigenomics Market Size Growth Rate by Application (2014-2019)
3 Global Personalized Medicine and Epigenomics by Players
3.1 Global Personalized Medicine and Epigenomics Market Size Market Share by Players
3.1.1 Global Personalized Medicine and Epigenomics Market Size by Players (2017-2019)
3.1.2 Global Personalized Medicine and Epigenomics Market Size Market Share by Players (2017-2019)
3.2 Global Personalized Medicine and Epigenomics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Personalized Medicine and Epigenomics by Regions
4.1 Personalized Medicine and Epigenomics Market Size by Regions
4.2 Americas Personalized Medicine and Epigenomics Market Size Growth
4.3 APAC Personalized Medicine and Epigenomics Market Size Growth
4.4 Europe Personalized Medicine and Epigenomics Market Size Growth
4.5 Middle East & Africa Personalized Medicine and Epigenomics Market Size Growth
5 Americas
5.1 Americas Personalized Medicine and Epigenomics Market Size by Countries
5.2 Americas Personalized Medicine and Epigenomics Market Size by Type
5.3 Americas Personalized Medicine and Epigenomics Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Personalized Medicine and Epigenomics Market Size by Countries
6.2 APAC Personalized Medicine and Epigenomics Market Size by Type
6.3 APAC Personalized Medicine and Epigenomics Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Personalized Medicine and Epigenomics by Countries
7.2 Europe Personalized Medicine and Epigenomics Market Size by Type
7.3 Europe Personalized Medicine and Epigenomics Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Personalized Medicine and Epigenomics by Countries
8.2 Middle East & Africa Personalized Medicine and Epigenomics Market Size by Type
8.3 Middle East & Africa Personalized Medicine and Epigenomics Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Personalized Medicine and Epigenomics Market Forecast
10.1 Global Personalized Medicine and Epigenomics Market Size Forecast (2019-2024)
10.2 Global Personalized Medicine and Epigenomics Forecast by Regions
10.2.1 Global Personalized Medicine and Epigenomics Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Personalized Medicine and Epigenomics Forecast by Type
10.8 Global Personalized Medicine and Epigenomics Forecast by Application
11 Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Company Details
11.1.2 Personalized Medicine and Epigenomics Product Offered
11.1.3 Abbott Laboratories Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Abbott Laboratories News
11.2 Affymetrix
11.2.1 Company Details
11.2.2 Personalized Medicine and Epigenomics Product Offered
11.2.3 Affymetrix Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Affymetrix News
11.3 Agilent Technologies
11.3.1 Company Details
11.3.2 Personalized Medicine and Epigenomics Product Offered
11.3.3 Agilent Technologies Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Agilent Technologies News
11.4 Astellas Pharmaceuticals
11.4.1 Company Details
11.4.2 Personalized Medicine and Epigenomics Product Offered
11.4.3 Astellas Pharmaceuticals Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Astellas Pharmaceuticals News
11.5 BAYER AG
11.5.1 Company Details
11.5.2 Personalized Medicine and Epigenomics Product Offered
11.5.3 BAYER AG Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 BAYER AG News
11.6 Bio Vision
11.6.1 Company Details
11.6.2 Personalized Medicine and Epigenomics Product Offered
11.6.3 Bio Vision Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Bio Vision News
11.7 Celgene Corp.
11.7.1 Company Details
11.7.2 Personalized Medicine and Epigenomics Product Offered
11.7.3 Celgene Corp. Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Celgene Corp. News
11.8 Emd Millipore
11.8.1 Company Details
11.8.2 Personalized Medicine and Epigenomics Product Offered
11.8.3 Emd Millipore Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Emd Millipore News
11.9 Epigenomics AG
11.9.1 Company Details
11.9.2 Personalized Medicine and Epigenomics Product Offered
11.9.3 Epigenomics AG Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Epigenomics AG News
11.10 Epigentex
11.10.1 Company Details
11.10.2 Personalized Medicine and Epigenomics Product Offered
11.10.3 Epigentex Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 Epigentex News
11.11 Envivo Pharmaceuticals (Forum Pharmaceutricals)
11.12 Gilead Sciences
11.13 Glaxosmithkline
11.14 Illumina Inc.
11.15 Johnson & Johnson
11.16 Karus Therapeutics Limited
11.17 Laboratory Corp. Of America Holdings
11.18 LES Laboratoires Servier
11.19 Merck
11.20 Naturewise Biotech & Medicals Corp.
11.21 Novartis Pharma AG
11.22 Oncolys Biopharma Inc.
11.23 Orchid Chemicals & Pharmaceuticals Limited
11.24 Progen Pharmaceuticals Limited
11.25 Quest Diagnostics
11.26 Roche Holding AG
11.27 Rubicon Genomics
11.28 Takeda Pharmaceutical Company Limited
12 Research Findings and Conclusion
